Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-25 @ 9:27 PM
Study NCT ID:
NCT00836056
Status:
COMPLETED
Last Update Posted:
2024-08-19
First Post:
2009-02-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
2003-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-03
First Submit QC Date:
None
Study First Post Date:
2009-02-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-06-18
Results First Submit QC Date:
None
Results First Post Date:
2009-07-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-15
Last Update Post Date:
2024-08-19
Last Update Post Date Type:
ACTUAL